Entrepreneur and investor Mark Cuban stated on X today, October 18, that manufacturing could return to the United States through advancements in artificial intelligence and robotics. Cuban posted, "It’s really simple. Our Robots and AI vs their Robots and AI. If we can catch up on robotics/software, and can stay ahead on AI, there is zero reason manufacturing won’t come back, or initiate here. At Cost Plus Drugs, the only thing holding us back from making generic drugs cheaper in Dallas than we can buy from Asia, are the fees we have to pay."
Cuban's remarks arrive as discussions about reshoring production and the impact of technology on industry continue. Recent Gokhshtein Media coverage has highlighted the broader economic implications of AI, with Anthony Pompliano suggesting Bitcoin as an AI disruption hedge. Other reports have focused on specific sectors, such as TSMC's stock valuation despite profit surges, and Circle's revenue performance, indicating dynamic shifts across tech and finance.
Cuban's view suggests that technological superiority in AI and robotics could overcome current cost advantages of overseas production, potentially revitalizing the US industrial base. He points to regulatory or administrative "fees" as a key impediment, implying that policy adjustments could further accelerate this shift. His specific example with Cost Plus Drugs highlights the potential for domestic production to compete on price, contingent on addressing these non-labor costs. This perspective indicates a future where advanced automation could redefine global supply chains.
